Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Description

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Conditions

Lymphoma, Non-Hodgkin, Hodgkin's Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Condition
Lymphoma, Non-Hodgkin
Intervention / Treatment

-

Contacts and Locations

Stanford

Stanford University School of Medicine, Stanford, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
  • * Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
  • * A routine procedure for tissue collection is planned.
  • * Ability to understand and the willingness to sign a written informed consent.
  • * Patients without NHL or Hodgkin's disease

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Ronald Levy, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2099-01